Skip to main content

HomeResearchN-Acetyl Semax

CategoryCognitive
SafetyLow Risk
StatusResearch Only

N-Acetyl Semax

NA-Semax · N-Acetyl Semax Amidate · NA-Semax Amidate

CategoryCognitive
Half-life
Routeintranasal, subcutaneous
RiskLow Risk
Providers4 listed

About N-Acetyl Semax

Same ACTH(4-7) core as Semax, but structural modifications resist peptidase degradation. Enhances BDNF expression, supports dopaminergic and serotonergic neurotransmission, and modulates NMDA receptor activity.

An acetylated and amidated derivative of Semax with enhanced enzymatic stability and prolonged activity. N-terminal acetylation and C-terminal amidation protect the peptide from degradation, extending its nootropic and neuroprotective effects versus base Semax.

Research Areas

cognitive enhancementmemoryneuroprotectionmood support

Regulatory & Evidence

Risk Profile

Low Risk

Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Safety Notes

Low Risk

Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.

Reported contraindications & considerations

Cardiovascular ConditionPregnant Or Nursing

Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.

Where to Find N-Acetyl Semax

4 providers

Frequently Asked Questions — N-Acetyl Semax

An acetylated and amidated derivative of Semax with enhanced enzymatic stability and prolonged activity. N-terminal acetylation and C-terminal amidation protect the peptide from degradation, extending its nootropic and neuroprotective effects versus base Semax.

cognitive enhancement, memory, neuroprotection, mood support, focus.

4 providers in the directory currently offer N-Acetyl Semax.

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.